Revance Therapeutics Releases Third Quarter 2015 Results

Go back to Revance Therapeutics Releases Third Quarter 2015 Results
REVANCE THERAP (NASDAQ: RVNC) Delayed: 3.65 --0 (-0%)
Previous Close $3.65    52 Week High $41.12 
Open $3.65    52 Week Low $12.35 
Day High $3.65    P/E N/A 
Day Low $3.65    EPS $-27.14 
Volume 400,000